|
Globally drug sales are increasing however sales in the European market drug sales are notably lower than in the United States.
Jurgen Dormann, Chairman of the Board for Aventis noted that sales of Aventis products in the USA increased 39% in the First Quarter of 2000 versus the first quarter of 1999. During the same period of time sales of these products only increased 1% in the UK, 7% in France and decreased -1% in Germany and -2% in Italy. Further study needs to be done to determine why sales have increased in the United States but declined in many European countries. Aventis is a world leader in life sciences products. Aventis Pharma AG, headquartered in Frankfurt, Germany Sales for three of Aventis products Lovenox, for the prevention and treatment of thrombosis, Allegra for the treatment of allergies and Taxotere for the treatment of breast cancer amounted to $500 million
It is a time to review marketing techniques and methodology fused to market pharmaceutical products in the United States. What is being done successfully and how are consumers finding out about specific products? What successful techniques can be introduced into the European and Asian markets?
About the Author
Marge Bitetti has devoted herself to being a professional writer for the past 17 years. During her career she has written hundreds of newspaper and magazine articles. Her work includes all aspects of non-fiction writing: articles, reports, corporate and educational scripts, newsletters, and books. She has worked both as author and as ghostwriter.
|
CD/Documentation Home Page
